Gao ZB - Search Results

1

Naphthylisoquinoline alkaloids, a new structural template inhibitor of Nav1.7 sodium channel.

Wang QQ, Wang L, Zhang WB, Tang CP, Chen XQ, Zheng YM, Yao S, Gao ZB, Ye Y. Wang QQ, et al. Among authors: gao zb. Acta Pharmacol Sin. 2023 Sep;44(9):1768-1776. doi: 10.1038/s41401-023-01084-9. Epub 2023 May 4. Acta Pharmacol Sin. 2023. PMID: 37142682 Free PMC article.

2

Inhibition of excitatory synaptic transmission by trans-resveratrol in rat hippocampus.

Gao ZB, Chen XQ, Hu GY. Gao ZB, et al. Brain Res. 2006 Sep 21;1111(1):41-7. doi: 10.1016/j.brainres.2006.06.096. Epub 2006 Jul 31. Brain Res. 2006. PMID: 16876771

3

Electrophysiological characterization of a novel Kv channel blocker N,N'-[oxybis(2,1-ethanediyloxy-2,1-ethanediyl) ]bis(4-methyl)-benzenesulfonamide found in virtual screening.

Gao ZB, Chen XQ, Jiang HL, Liu H, Hu GY. Gao ZB, et al. Acta Pharmacol Sin. 2008 Apr;29(4):405-12. doi: 10.1111/j.1745-7254.2008.00777.x. Acta Pharmacol Sin. 2008. PMID: 18358085

4

Comparison of the effects of DC031050, a class III antiarrhythmic agent, on hERG channel and three neuronal potassium channels.

Li P, Sun HF, Zhou PZ, Ma CY, Hu GY, Jiang HL, Li M, Liu H, Gao ZB. Li P, et al. Among authors: gao zb. Acta Pharmacol Sin. 2012 Jun;33(6):728-36. doi: 10.1038/aps.2012.41. Epub 2012 May 21. Acta Pharmacol Sin. 2012. PMID: 22609836 Free PMC article.

5

Hexachlorophene is a potent KCNQ1/KCNE1 potassium channel activator which rescues LQTs mutants.

Zheng Y, Zhu X, Zhou P, Lan X, Xu H, Li M, Gao Z. Zheng Y, et al. PLoS One. 2012;7(12):e51820. doi: 10.1371/journal.pone.0051820. Epub 2012 Dec 12. PLoS One. 2012. PMID: 23251633 Free PMC article.

6

Discovery of a retigabine derivative that inhibits KCNQ2 potassium channels.

Hu HN, Zhou PZ, Chen F, Li M, Nan FJ, Gao ZB. Hu HN, et al. Among authors: gao zb. Acta Pharmacol Sin. 2013 Oct;34(10):1359-66. doi: 10.1038/aps.2013.79. Epub 2013 Aug 12. Acta Pharmacol Sin. 2013. PMID: 23933653 Free PMC article.

7

The human ether-a-go-go-related gene activator NS1643 enhances epilepsy-associated KCNQ channels.

Li P, Chen X, Zhang Q, Zheng Y, Jiang H, Yang H, Gao Z. Li P, et al. J Pharmacol Exp Ther. 2014 Dec;351(3):596-604. doi: 10.1124/jpet.114.217703. Epub 2014 Sep 17. J Pharmacol Exp Ther. 2014. PMID: 25232191

8

P-retigabine: an N-propargyled retigabine with improved brain distribution and enhanced antiepileptic activity.

Zhou P, Zhang Y, Xu H, Chen F, Chen X, Li X, Pi X, Wang L, Zhan L, Nan F, Gao Z. Zhou P, et al. Mol Pharmacol. 2015 Jan;87(1):31-8. doi: 10.1124/mol.114.095190. Epub 2014 Oct 15. Mol Pharmacol. 2015. PMID: 25319542

9

Activation of peripheral KCNQ channels relieves gout pain.

Zheng Y, Xu H, Zhan L, Zhou X, Chen X, Gao Z. Zheng Y, et al. Pain. 2015 Jun;156(6):1025-1035. doi: 10.1097/j.pain.0000000000000122. Pain. 2015. PMID: 25735002 Free PMC article.

10

Novel KCNQ2 channel activators discovered using fluorescence-based and automated patch-clamp-based high-throughput screening techniques.

Yue JF, Qiao GH, Liu N, Nan FJ, Gao ZB. Yue JF, et al. Among authors: gao zb. Acta Pharmacol Sin. 2016 Jan;37(1):105-10. doi: 10.1038/aps.2015.142. Acta Pharmacol Sin. 2016. PMID: 26725738 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

124 results

Search Page

Filters